Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease Using Commercial Mesenchymal Stem Cell Products

Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease Using Commercial Mesenchymal Stem Cell Products

Acute graft-versus-host disease (GVHD) is a life-threatening complication that can develop after allogeneic hematopoietic stem cell transplantation. In particular, the prognosis of patients with steroid-refractory acute GVHD is extremely poor. Ryoncil™ (remestemcel-L), a human bone marrow-derived me...

Full description

Bibliographic Details
Main Authors: Makoto Murata, Takanori Teshima
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Immunology
Subjects:
graft-versus-host disease (GVHD)
mesenchymal stem cell (MSC)
steroid
ruxolitinib
thymoglobulin
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.724380/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.724380/full

Similar Items